Changes

Jump to navigation Jump to search
Line 203: Line 203:  
*'''Sulfadiazine and pyrimethamine combination, 'Re-Balance'''': administered PO daily for a minimum of 90 days. Due to availability and ease of administration, some use an off-label regimen of trimethoprimsulfa tablets with pyrimethamine tablets.  ''Mode of action'': trimethoprim, sulfadiazine, and pyrimethamine all inhibit enzymes of folic acid synthesis.  ''Efficacy'': 61.5% improvement by one clinical grade.(98 in furr)''Potential adverse effects'': bone marrow suppression (mild anaemia, leucopenia, neutropenia, thrombocytopenia), fever, anorexia, depression, acute worsening of ataxiam altered reproductive performance in stallions (19 in IVIS 4), congenital defects(20 in IVIS 4) and abortion.  Folic acid deficiency may also cause gastrointestinal disturbances such as glossitis.(18 in IVIS 4) Blood dyscrazias are typically self-limiting and resolve on withdrawal of treatment. (Furr)
 
*'''Sulfadiazine and pyrimethamine combination, 'Re-Balance'''': administered PO daily for a minimum of 90 days. Due to availability and ease of administration, some use an off-label regimen of trimethoprimsulfa tablets with pyrimethamine tablets.  ''Mode of action'': trimethoprim, sulfadiazine, and pyrimethamine all inhibit enzymes of folic acid synthesis.  ''Efficacy'': 61.5% improvement by one clinical grade.(98 in furr)''Potential adverse effects'': bone marrow suppression (mild anaemia, leucopenia, neutropenia, thrombocytopenia), fever, anorexia, depression, acute worsening of ataxiam altered reproductive performance in stallions (19 in IVIS 4), congenital defects(20 in IVIS 4) and abortion.  Folic acid deficiency may also cause gastrointestinal disturbances such as glossitis.(18 in IVIS 4) Blood dyscrazias are typically self-limiting and resolve on withdrawal of treatment. (Furr)
   −
 
+
*''Ponazuril (Marquis, Bayer Animal Health)''': ''Efficacy'': well absorbed PO, achieves steady state therapeutic concentration in CSF within 3 days(100 in Furr), clinical response within 10 days, 60% improvement by at least one clinical grade, 8% relapse within 90 days of stopping treatment(91 in Furr).  V safe, no sstemci toxicity even at high doses (101 in Furr), use in pregannt animals is off-label, feeding corn oil immediately prior to admin may enahcne absrobption of durg (103 in Furr)
Ponazuril (Marquis, Bayer Animal Health) - 1st FDA-approved drug for EPM, well absorbed PO, achieves steady state therapeutic concentration in 3days in CSF of horses  (100 in Furr).  In filed efficacy study improvement bny at least one clincal gradein 60%, 8% relase after 90days of stopping treatment (91 in Furr), resposne wihtin 10days.  V safe, no sstemci toxicity even at high doses (101 in Furr), use in pregannt animals is off-label, feeding corn oil immediately prior to admin may enahcne absrobption of durg (103 in Furr)
   
Ponazuril is a triazinetrione antiprotozoal drug that targets the “apicoplast” organelle and inhibits energy metabolism (respiratory chains). The label dosage regimen PO daily for 28 days.  A multi-center field study - no adverse effects were noted.  However, information provided by the manufacturer reports “unusual daily observations” in eight animals that may have been related to treatment including blisters on nose and mouth, skin rash or hives, loose stools, mild colic, and a seizure.(IVIS 4)
 
Ponazuril is a triazinetrione antiprotozoal drug that targets the “apicoplast” organelle and inhibits energy metabolism (respiratory chains). The label dosage regimen PO daily for 28 days.  A multi-center field study - no adverse effects were noted.  However, information provided by the manufacturer reports “unusual daily observations” in eight animals that may have been related to treatment including blisters on nose and mouth, skin rash or hives, loose stools, mild colic, and a seizure.(IVIS 4)
 
Protocols involving intermittent administration of ponazuril may have application in prevention of EPM. (Mackay, R.J, Tanhauser, S.T, Gillis, K.D, Mayhew, I.G, Kennedy, T.J (2008) Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses.  Am J Vet Res, 69(3):396-402.
 
Protocols involving intermittent administration of ponazuril may have application in prevention of EPM. (Mackay, R.J, Tanhauser, S.T, Gillis, K.D, Mayhew, I.G, Kennedy, T.J (2008) Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses.  Am J Vet Res, 69(3):396-402.
1,406

edits

Navigation menu